Back to the main directory
EarningsReview / Equity
- What’s the buzz? by BNP Paribas Exane
- Digital Industries recovery to continue by BNP Paribas Exane
- Thoughts into Q1 results by BNP Paribas Exane
- Look beyond Germany by BNP Paribas Exane
- Everything is on the Table: 4Q EPS Preview; Cautiously Biased by BNP Paribas Exane
- Earning(s) its due by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Tariff Round 2 by BNP Paribas Exane
- Osmosun - CA 2024 by MidCap Partners
- Median Technologies - Résultats finaux de l’étude RELIVE : calendrier confirmé dans la detection et le diagnostic du cancer du poumon by MidCap Partners
- Median Technologies - Final Results of the RELIVE Study: Confirmed Timeline for Lung Cancer Detection and Diagnosis by MidCap Partners
- Gentili Mosconi - Andrà Tutto Bene! by MidCap Partners
- Acquires a minority stake in Aiper by BNP Paribas Exane
- Le Pen verdict; positive for French infra stocks? by BNP Paribas Exane
- FCX, STRATEGY, FQM, AAL, STEEL US by BNP Paribas Exane
- INVEST SECURITIES - DRONE VOLT : En mesure de se concentrer sur l'opérationnel - ACHAT vs NEUTRE, OC 0,85€ vs 0,95€ by Invest Securities
- Solid H1 - onwards to the break-up by BNP Paribas Exane
- Danish Competition probe into P&C insurance by BNP Paribas Exane
- U.S. Nielsen Quick Take - Data Ending 03/22/25 by BNP Paribas Exane
- US Food/HPC Data (Nielsen, Mar'25): Danone & consumer health weaker, beauty somewhat improved by BNP Paribas Exane
- US Total Beverages Alcohol Data (Nielsen, Q1’25): further deterioration by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Q1 pre-close call company feedback by BNP Paribas Exane
- Pre-close call feedback: cautious on pricing and utilization by BNP Paribas Exane
- Itaú BBA on Kora Saúde: Lower Operational Beds and Soft Average Ticket Offset Strong Growth in Oncology by Itau